RCAN2 and colorectal carcinoma: Subsequently, we performed IHC to investigate the correlation between KRAS mutation and RCAN2 expression at the IF in early-stage human CRC specimens, as it is known that KRAS mutations occur relatively early during multistep carcinogenesis and that RCAN2 is potentially activated by various unknown stimuli.